Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Nizatidine
Cat. No.:
OB0225LY-0167
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Nizatidine is an H2 receptor antagonist used to reduce gastric acid secretion.
Synonym:
Axid; Acinon; Zanizal; 76963-41-2; (E)-N-(2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine; N-(2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine; (E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-(2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
CAS No.:
76963-41-2
Compound CID:
3033637
Formula:
C12H21N5O2S2
Formula Weight:
331.46
Specification
Relative Density:
1.249 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Nizatidine can be used to study the mechanisms of gastrointestinal diseases or play an important role in digestive system research.
Library Information
Targets:
Histamine receptor
Receptors:
AChE; H2 receptor
Pathways:
GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-3
Plate Location:
a10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 181.02 mM
Water Max Solubility:
26 mg/mL; 78.4 mM
Ethanol Max Solubility:
15 mg/mL; 45.3 mM
